CDg16
CDg16 is a selective fluorescent dye targeting SLC18B1 (λabs/λem=458/544 nm) that is actively transported into lysosomal vesicles of activated macrophages independent of the endocytic pathway. CDg16 enables highly specific vesicle localization in live cells. CDg16 exhibits no cytotoxicity and accurately distinguishes activated M1 and M2 subsets from different origins. CDg16 shows low background staining in non-activated cells and normal organs, making it suitable for time-lapse imaging. In preclinical animal models of inflammatory sites, atherosclerotic plaques and liver inflammation, CDg16 allows visualization of activated macrophages. CDg16 can be used to study inflammation-related diseases and atherosclerosis.
For research use only. We do not sell to patients.
- Formula: C27H23N5O3
- Molecular Weight:465.50
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
CDg16 (200 nM; 30 min-1 h) is selectively transported into activated macrophages via the solute carrier transporter SLC18B1[1].
CDg16 (1 μM; 1 h) selectively stains activated Raw264.7 macrophages, distinguishing them from non-activated macrophages[1].
CDg16 (200 nM-1 μM; 30 min-36 h) selectively stains activated M1 and M2 macrophages (including Raw264.7, primary peritoneal, microglia, human monocyte-derived, and THP-1 cells) via Slc18b1/SLC18B1-mediated uptake, with first detectable signals at 8 h post-activation and no observed cellular toxicity over 36 h[2].
CDg16 (200 nM-1 μM; 30 min-1 h) is a selective substrate of the Slc18b1/SLC18B1 transporter, with enhanced CDg16 uptake in SLC18B1-overexpressing HeLa cells, colocalization of CDg16 with SLC18B1, and reduced CDg16 uptake in Slc18b1-knockout Raw264.7 activated macrophages[2].
CDg16 selectively accumulates in sub-lysosomal vesicles of activated M1 and M2 macrophages in vitro via the Slc18b1/SLC18B1 transporter, enabling specific identification of these activated macrophage types (λabs/λem=458/544 nm)[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ApoE knockout mice (western diet-induced atherosclerotic plaque formation)[2]
-
Dosage:500 μM, 200 μL per 20 g mouse
-
Administration:i.v.; single dose
-
Result:Detected high fluorescence signals in severely atherosclerotic areas of the root of aorta arch, thoracic aorta, and right brachiocephalic artery.
Colocalized with CD86 and iNOS markers for activated macrophages in atherosclerotic plaques.
Detected very low fluorescence in other organs except fat pads, which showed lower signal intensity than plaque areas.
Stained 47.7% of CD45+CD86+ M1 macrophages, 41.6% of CD45+CD38+ M1 macrophages, and 2.1% of CD45+CD206+ M2 macrophages in isolated aorta tissue cells.
Chemical Information
-
Molecular Weight 465.50
-
Formula C27H23N5O3
-
SMILES
NC1=CC=C2C(N=C(C=C(NC(CN(CC3=CC=C(C)C=C3)C(C4=CC=NO4)=O)=O)C=C5)C5=C2)=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Research Protocol for Cardiovascular Diseases
Cardiovascular disease can be modeled as maladaptive cardiac remodeling, where ischemic injury or pressure overload activates inflammatory signaling, fibroblast activation, extracellular-matrix deposition, cardiomyocyte hypertrophy, vascular remodeling, and progressive ventricular dysfunction. The TGF-β/SMAD axis is a central profibrotic pathway after myocardial injury and pressure overload, while innate immune and cytokine pathways regulate leukocyte recruitment, scar formation, and adverse remodeling. Key unresolved questions include which inflammatory signals are reparative versus harmful, when fibrosis is protective versus maladaptive, and whether pathway inhibition improves function without weakening necessary infarct healing or compensatory remodeling.
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
[2]. Park SJ, et al. Imaging inflammation using an activated macrophage probe with Slc18b1 as the activation-selective gating target. Nat Commun. 2019;10(1):1111. Published 2019 Mar 7. [Content Brief]
[3]. Liu X, et al. Fluorescent probe strategy for live cell distinction. Chem Soc Rev. 2022;51(5):1573-1591. Published 2022 Mar 7. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)